PRESS RELEASE ARLINGTON, VA – September 7, 2022 – Science and Medicine Group Inc. (SMG), a data intelligence company providing actionable insights about hard-to-reach audiences in life sciences and healthcare, today announced that it has acquired the assets of Amplion...
Amplion’s Machine Learning Platform Accelerates Precision Medicine Collaboration Dx:Revenue™ solution rapidly identifies and qualifies drug and test developer partnership opportunities Effective partnerships between pharmaceutical companies, biotechs, academia,...
Biomarker Intelligence company to aggressively accelerate sales, marketing and execution of product roadmap Amplion, an Oregon-based Biomarker Intelligence company, announced the successful close of its Series A financing led by Greycroft with participation from...